Generative AI Finds Its Footing in Drug Development
Pictured: Robot hand holding microscope, pill bottles and DNA/Taylor Tieden for BioSpace Xaira Therapeutics launched April 23 with $1 billion behind it to apply artificial intelligence to drug discovery and development. It was the largest initial …